American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

The American Association of Clinical Endocrinologists/American College of Endocrinology Medical Guidelines for Clinical Practice are systematically developed statements to assist healthcare professionals in medical decision making for specific clinical conditions. Most of the content herein is based on literature reviews. In areas of uncertainty, professional judgment was applied. These guidelines are a working document that reflects the state of the field at the time of publication. Because rapid changes in this area are expected, periodic revisions are inevitable. We encourage medical professionals to use this information in conjunction with their best clinical judgment. The presented recommendations may not be appropriate in all situations. Any decision by practitioners to apply these guidelines must be made in light of local resources and individual patient circumstances. Abbreviations: A1C = hemoglobin A1c AACE = American Association of Clinical Endocrinologists ACCORD = Action to Control Cardiovascu...

[1]  D. Willcox,et al.  The Okinawan Diet: Health Implications of a Low-Calorie, Nutrient-Dense, Antioxidant-Rich Dietary Pattern Low in Glycemic Load , 2009, Journal of the American College of Nutrition.

[2]  T. Erlinger,et al.  Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. , 2003, Diabetes care.

[3]  P. Bennett,et al.  Congenital Susceptibility to NIDDM: Role of Intrauterine Environment , 1988, Diabetes.

[4]  E. Mannucci,et al.  Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. , 2013, The Journal of clinical psychiatry.

[5]  G. Bray A Guide to Obesity and the Metabolic Syndrome: Origins and Treatment , 2011 .

[6]  M. Pathy,et al.  Principles and practice of geriatric medicine , 2005 .

[7]  H. Yoshikawa,et al.  Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model , 2010, Experimental Neurology.

[8]  L. Melton,et al.  Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. , 1999, Diabetes care.

[9]  P. Donnan,et al.  Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a retrospective cohort study of resource use. , 2000, Diabetes care.

[10]  R. Kirsner,et al.  Clinical practice. Neuropathic diabetic foot ulcers. , 2004, The New England journal of medicine.

[11]  H. Parving,et al.  Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial , 2008, The Lancet.

[12]  Nicola J Cooper,et al.  Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[13]  L. Jovanovic,et al.  Maternal Efficacy and Safety Outcomes in a Randomized, Controlled Trial Comparing Insulin Detemir With NPH Insulin in 310 Pregnant Women With Type 1 Diabetes , 2012, Diabetes Care.

[14]  V. Basevi,et al.  Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.

[15]  M. Molitch,et al.  A Randomized Trial of Two Weight-Based Doses of Insulin Glargine and Glulisine in Hospitalized Subjects With Type 2 Diabetes and Renal Insufficiency , 2012, Diabetes Care.

[16]  S. Tunis,et al.  Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada. , 2009, Clinical therapeutics.

[17]  L. Rydén,et al.  Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. , 2004, European heart journal.

[18]  S. Cummings,et al.  Thiazolidinedione use and bone loss in older diabetic adults. , 2006, The Journal of clinical endocrinology and metabolism.

[19]  R. Hughes,et al.  ENHANCED GLUCOSE CONTROL FOR PREVENTING AND TREATING DIABETIC NEUROPATHY , 2012, The Cochrane database of systematic reviews.

[20]  G I Bell,et al.  Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. , 2001, The New England journal of medicine.

[21]  R. Holman,et al.  10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.

[22]  Michael Bailey,et al.  Hypoglycemia and outcome in critically ill patients. , 2010, Mayo Clinic proceedings.

[23]  A. Vinik,et al.  Quantitative measurement of cutaneous perception in diabetic neuropathy , 1995, Muscle & nerve.

[24]  J. Lau,et al.  Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. , 2007, JAMA.

[25]  Devjit Tripathy,et al.  Actos Now for the prevention of diabetes (ACT NOW) study , 2009, BMC endocrine disorders.

[26]  Curt D. Furberg,et al.  Lipoprotein Management in Patients With Cardiometabolic Risk , 2008, Diabetes Care.

[27]  V. Mohan Epidemiology of Complications of Diabetes , 2014 .

[28]  R. Ross,et al.  Trial of prevention and reduction of obesity through active living in clinical settings: a randomized controlled trial. , 2012, Archives of internal medicine.

[29]  R. Bilous,et al.  KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  M. Clearfield Combination Lipid Therapy in Type 2 Diabetes , 2011, Current atherosclerosis reports.

[31]  G. Cresci,et al.  Postoperative diet advancement: surgical dogma vs evidence-based medicine. , 2011, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[32]  K. Schulman,et al.  Cost-effectiveness of sensor-augmented pump therapy in adults with type 1 diabetes in the United States. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[33]  D. Berrigan,et al.  Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation. , 2006, Cancer research.

[34]  B. Davis,et al.  Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2005, Archives of internal medicine.

[35]  G. Umpierrez,et al.  Glucose variability is an independent predictor of mortality in hospitalized patients treated with total parenteral nutrition. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[36]  Silvio E. Inzucchi,et al.  Management of Hyperglycemia in the Hospital Setting , 2006 .

[37]  J. Borén,et al.  Review the Polygenic Nature of Hypertriglyceridaemia: Implications for Defi Nition, Diagnosis, and Management , 2022 .

[38]  Deepak L. Bhatt,et al.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. , 2014, The New England journal of medicine.

[39]  Roy A Kaplan,et al.  Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study , 1998, Diabetes Care.

[40]  Judith Wylie-Rosett,et al.  Nutrition Recommendations and Interventions for Diabetes , 2008, Diabetes Care.

[41]  F. A. Gries,et al.  The Epidemiology of Diabetic Neuropathy , 1993 .

[42]  C. Lindgren,et al.  Common Variants in Maturity-Onset Diabetes of the Young Genes and Future Risk of Type 2 Diabetes , 2008, Diabetes.

[43]  O. Ganda,et al.  Refining lipoprotein assessment in diabetes: apolipoprotein B makes sense. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[44]  K. Jones,et al.  Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. , 2002, Diabetes care.

[45]  F. Nieto,et al.  Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus , 2000 .

[46]  R. Heine,et al.  Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study , 2010, The Lancet.

[47]  Henry Buchwald,et al.  Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.

[48]  D. Nieman,et al.  Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates , 2010 .

[49]  C. Apovian,et al.  Nutrition Recommendations and Interventions for Diabetes–2006 , 2006, Diabetes Care.

[50]  M. Laakso,et al.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.

[51]  Dennis D. Kim,et al.  Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin , 2006, Diabetes/metabolism research and reviews.

[52]  T. Wong,et al.  Effects of treatments for symptoms of painful diabetic neuropathy: systematic review , 2007, BMJ : British Medical Journal.

[53]  Richard Hellman,et al.  Comprehensive foot examination and risk assessment. A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. , 2008, Physical therapy.

[54]  J. Gallivan,et al.  National Diabetes Education Program: opportunities and challenges. The National Diabetes Education Program Strategic Planning Committee. , 1998, Journal of the American Dietetic Association.

[55]  P. O'Neil,et al.  Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study , 2012, Obesity.

[56]  J. Zonszein,et al.  Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. , 2011, The American journal of medicine.

[57]  D. Flum,et al.  Importance of Perioperative Glycemic Control in General Surgery: A Report From the Surgical Care and Outcomes Assessment Program , 2012, Annals of surgery.

[58]  G. Bray,et al.  Pharmacologic Treatment Options for Obesity: What Is Old Is New Again , 2013, Current Hypertension Reports.

[59]  Matthew D. Davis,et al.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. , 2000, The New England journal of medicine.

[60]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[61]  P. Cavanagh,et al.  Assessment and management of foot disease in patients with diabetes. , 1994, The New England journal of medicine.

[62]  Seppo Lehto,et al.  Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects. , 2005, Diabetes care.

[63]  B. Zinman,et al.  Rosiglitazone-Associated Fractures in Type 2 Diabetes , 2008, Diabetes Care.

[64]  E. Wagner,et al.  Medical Conditions and Motor Vehicle Collision Injuries in Older Adults , 1994, Journal of the American Geriatrics Society.

[65]  A. Vinik,et al.  Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management , 2011, Diabetes/metabolism research and reviews.

[66]  G. Umpierrez,et al.  Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery , 2010, Diabetes Care.

[67]  D. Nathan,et al.  Long-term complications of diabetes mellitus. , 1993, The New England journal of medicine.

[68]  William Weintraub,et al.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. , 2011, The New England journal of medicine.

[69]  L. Niskanen,et al.  Comparison of Insulin Regimens in Patients with Non-Insulin Dependent Diabetes Mellitus , 1993 .

[70]  A. Farmer,et al.  Three-year efficacy of complex insulin regimens in type 2 diabetes. , 2009, The New England journal of medicine.

[71]  C. Iber,et al.  A multisite randomized trial of portable sleep studies and positive airway pressure autotitration versus laboratory-based polysomnography for the diagnosis and treatment of obstructive sleep apnea: the HomePAP study. , 2012, Sleep.

[72]  James B Talmage,et al.  Factors Associated With Obstructive Sleep Apnea Among Commercial Motor Vehicle Drivers , 2011, Journal of occupational and environmental medicine.

[73]  Joyce Y. Wu,et al.  Investigating maturity onset diabetes of the young. , 2009, The Clinical biochemist. Reviews.

[74]  T. Marshall,et al.  Dietary Guidelines for Americans, 2010: an update. , 2011, Journal of the American Dental Association.

[75]  C. Schmid,et al.  Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. , 2004, Archives of internal medicine.

[76]  J. Mann,et al.  Trans fatty acids and cardiovascular health: translation of the evidence base. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[77]  M. Kivimäki,et al.  Antidepressant Medication Use, Weight Gain, and Risk of Type 2 Diabetes , 2010, Diabetes Care.

[78]  M. Marre,et al.  Adding Liraglutide to Oral Antidiabetic Drug Monotherapy: Efficacy and Weight Benefits , 2009, Postgraduate medicine.

[79]  B. Hutton,et al.  Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials. , 2004, The American journal of clinical nutrition.

[80]  A. Hofman,et al.  Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis , 2015, Diabetologia.

[81]  Rajiv Raman,et al.  The Sensitivity and Specificity of Nonmydriatic Digital Stereoscopic Retinal Imaging in Detecting Diabetic Retinopathy , 2007, Diabetes Care.

[82]  J. Garber,et al.  American Association of Clinical Endocrinologists and American College of Endocrinology Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists--2014 Update and the AACe G4G Program. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[83]  A. Palmer,et al.  Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK. , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[84]  H. Hanaire External insulin pump treatment in the day-to-day management of diabetes: benefits and future prospectives. , 2011, Diabetes & metabolism.

[85]  H. Rodbard,et al.  American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[86]  Bertram L Kasiske,et al.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. , 2011, Kidney international.

[87]  B. Fernhall,et al.  Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. , 2010, Medicine and science in sports and exercise.

[88]  Joseph L. Mills,et al.  Comprehensive fool examination and risk assessment: A report of the task force of the foot care interest group of the American diabetes association, with endorsement by the American association of clinical endocrinologists , 2008 .

[89]  J. Rosenstock,et al.  Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes , 2010, Diabetes, obesity & metabolism.

[90]  E. Araki,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.

[91]  L. Kozak,et al.  National Hospital Discharge Survey: 2003 annual summary with detailed diagnosis and procedure data. , 2006, Vital and health statistics. Series 13, Data from the National Health Survey.

[92]  F. Gries,et al.  Effects of Treatment With the Antioxidant α-Lipoic Acid on Cardiac Autonomic Neuropathy in NIDDM Patients: A 4-month randomized controlled multicenter trial (DEKAN Study) , 1997, Diabetes Care.

[93]  B. Zinman,et al.  Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) , 2009, Diabetes Care.

[94]  R. Manders,et al.  Low-intensity exercise reduces the prevalence of hyperglycemia in type 2 diabetes. , 2010, Medicine and science in sports and exercise.

[95]  E. van Cauter,et al.  Obstructive sleep apnea and type 2 diabetes: interacting epidemics. , 2008, Chest.

[96]  Z. Bloomgarden Sodium glucose transporter 2 inhibition: A new approach to diabetes treatment (抑制钠葡萄糖转运体2:一种新的糖尿病治疗方法) , 2013, Journal of diabetes.

[97]  Nicola Glover-Thomas,et al.  Mental Health Professionals , 2010 .

[98]  D. Sacks A1C Versus Glucose Testing: A Comparison , 2011, Diabetes Care.

[99]  G. Bray,et al.  American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[100]  B. Ammori,et al.  Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis , 2010, Expert opinion on pharmacotherapy.

[101]  F L Ferris,et al.  Treatment of diabetic retinopathy. , 1999, The New England journal of medicine.

[102]  Z. Bloomgarden,et al.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of hypertension. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[103]  J. Brunzell,et al.  Clinical practice. Hypertriglyceridemia. , 2007, The New England journal of medicine.

[104]  S. Gapstur,et al.  Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults , 2012, Diabetes Care.

[105]  R. Carney,et al.  Depression and poor glycemic control: a meta-analytic review of the literature. , 2000, Diabetes care.

[106]  M. Woodward,et al.  Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies , 2005, British Journal of Cancer.

[107]  Howard Wolpert,et al.  Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes , 2009, Diabetes Care.

[108]  T. Wadden,et al.  One‐year Weight Losses in the Look AHEAD Study: Factors Associated With Success , 2009, Obesity.

[109]  F. Greenway,et al.  Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial , 2010, The Lancet.

[110]  G. Gronseth,et al.  Distal symmetric polyneuropathy: A definition for clinical research , 2005, Neurology.

[111]  G. Hitman,et al.  Systematic review on urine albumin testing for early detection of diabetic complications. , 2005, Health technology assessment.

[112]  E. Kohner,et al.  Why some cases of retinopathy worsen when diabetic control improves , 1997, BMJ.

[113]  A. Vinik,et al.  The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. , 2005, Diabetes technology & therapeutics.

[114]  Martin Pitt,et al.  Can the Retinal Screening Interval Be Safely Increased to 2 Years for Type 2 Diabetic Patients Without Retinopathy? , 2012, Diabetes Care.

[115]  Braxton D Mitchell,et al.  The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. , 2003, Diabetes care.

[116]  F. Rubino,et al.  Bariatric surgery: an IDF statement for obese Type 2 diabetes. , 2011, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[117]  J. Leahy Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial) , 2008 .

[118]  D. Mozaffarian,et al.  Saturated Fat and Cardiometabolic Risk Factors, Coronary Heart Disease, Stroke, and Diabetes: a Fresh Look at the Evidence , 2010, Lipids.

[119]  Massimiliano Cazzaniga,et al.  Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis , 2010, Cancer Prevention Research.

[120]  B. Goldstein,et al.  Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes , 2010, BMC endocrine disorders.

[121]  G. Fonarow,et al.  An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. , 2014, Journal of the American College of Cardiology.

[122]  M. Taskinen Diabetic dyslipidaemia: from basic research to clinical practice* , 2003, Diabetologia.

[123]  D. Thurman,et al.  Association of statin use with peripheral neuropathy in the US population 40 years of age or older (美国40岁及以上人群的他汀使用情况与周围神经病变的关系) , 2013, Journal of diabetes.

[124]  A. Vinik,et al.  Neurovascular Function and Sudorimetry in Health and Disease , 2013, Current Diabetes Reports.

[125]  W. Garvey,et al.  Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-hr glucose values and effects of gender, race, and age. , 2014, Metabolic syndrome and related disorders.

[126]  D. Heisey,et al.  Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. , 2000, Kidney international.

[127]  K. Gadde,et al.  Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial , 2011, The Lancet.

[128]  C. Schmid,et al.  Long-term non-pharmacological weight loss interventions for adults with prediabetes. , 2005, The Cochrane database of systematic reviews.

[129]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[130]  Deborah J. Cook,et al.  Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data , 2009, Canadian Medical Association Journal.

[131]  S. Larsson,et al.  Diabetes mellitus and risk of colorectal cancer: a meta-analysis. , 2005, Journal of the National Cancer Institute.

[132]  W. Herman,et al.  Underdiagnosis of peripheral neuropathy in type 2 diabetes. , 2005, Diabetes care.

[133]  T. Wadden,et al.  Weight and Metabolic Outcomes After 2 Years on a Low-Carbohydrate Versus Low-Fat Diet , 2010 .

[134]  P. Cryer,et al.  Mechanisms of hypoglycemia-associated autonomic failure in diabetes. , 2013, The New England journal of medicine.

[135]  F. Pi‐Sunyer,et al.  Carbohydrate issues: type and amount. , 2008, Journal of the American Dietetic Association.

[136]  J. Derr,et al.  Problems with Gait and Posture in Neuropathic Patients with Insulin‐Dependent Diabetes Mellitus , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[137]  L. Rydén,et al.  Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart. , 2007, European heart journal.

[138]  M. Stumvoll,et al.  Reversal of hypoglycemia unawareness in a long-term type 1 diabetic patient by improvement of beta-adrenergic sensitivity after prevention of hypoglycemia. , 2000, The Journal of clinical endocrinology and metabolism.

[139]  W. M. Anderson,et al.  Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. , 2007, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[140]  M. Laakso,et al.  Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data , 2004, Diabetologia.

[141]  D. Leroith,et al.  Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression , 2009, Diabetes.

[142]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[143]  David R. Plas,et al.  Growth Factors Can Influence Cell Growth and Survival through Effects on Glucose Metabolism , 2001, Molecular and Cellular Biology.

[144]  Whei-Min Lin,et al.  Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. , 2004, Brain : a journal of neurology.

[145]  A. Farmer,et al.  Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials , 2012, Diabetologia.

[146]  G. Mamikunian,et al.  Cardiac Autonomic Imbalance in Newly Diagnosed and Established Diabetes Is Associated with Markers of Adipose Tissue Inflammation , 2011, Experimental diabetes research.

[147]  P. Cryer,et al.  Hypoglycemia in diabetes. , 2003, Diabetes care.

[148]  Everett M. Rogers,et al.  Consensus Development Conference , 1984 .

[149]  Ivana Vucenik,et al.  Annals of the New York Academy of Sciences Obesity and Cancer Risk: Evidence, Mechanisms, and Recommendations , 2022 .

[150]  C. Weyer,et al.  A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes. , 2002, Diabetes care.

[151]  P. Royle,et al.  The use of metformin in type 1 diabetes: a systematic review of efficacy , 2010, Diabetologia.

[152]  N. Marchionni,et al.  Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[153]  A. López,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.

[154]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[155]  L. Kennedy A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes , 2007 .

[156]  A. Al-Shaikh COMPARISON OF BASAL INSULIN ADDED TO ORAL AGENTS VERSUS TWICE - DAILY PREMIXED INSULIN AS INITIAL INSULIN THERAPY FOR TYPE 2 DIABETES , 2006 .

[157]  A. Garber Long-Acting Glucagon-Like Peptide 1 Receptor Agonists , 2011, Diabetes Care.

[158]  A. Bauman,et al.  Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. , 2007, Circulation.

[159]  P. Davidson,et al.  A Cause-and-Effect-Based Mathematical Curvilinear Model That Predicts the Effects of Self-Monitoring of Blood Glucose Frequency on Hemoglobin A1c and is Suitable for Statistical Correlations , 2007, Journal of diabetes science and technology.

[160]  S. Majumdar,et al.  Working-age adults with diabetes experience greater susceptibility to seasonal influenza: a population-based cohort study , 2014, Diabetologia.

[161]  J. Rosenstock,et al.  The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. , 2003, Diabetes care.

[162]  C. Mantzoros,et al.  Diabetes mellitus and risk of endometrial cancer: a meta-analysis , 2007, Diabetologia.

[163]  H. Krumholz,et al.  Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk , 2008, Circulation.

[164]  Limin Peng,et al.  Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes , 2013, Diabetes Care.

[165]  Matthew Page,et al.  Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. , 2010, The Cochrane database of systematic reviews.

[166]  H R Taylor,et al.  Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[167]  M. Landray,et al.  The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial , 2011, The Lancet.

[168]  O. Tanner Intensive versus Conventional Glucose Control in Critically Ill Patients , 2009 .

[169]  W. Frishman Effects of longterm fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trialKeech A, and the FIELD study investigators (Univ of Sydney, Australia; et al) Lancet 366:1849–1861, 2005§ , 2007 .

[170]  C. Bouchard,et al.  Bariatric surgery and long-term cardiovascular events. , 2012, JAMA.

[171]  G. Klingensmith,et al.  ISPAD clinical practice consensus guidelines 2009 compendium. Introduction. , 2009, Pediatric diabetes.

[172]  T Douglas Bradley,et al.  Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. , 2003, The New England journal of medicine.

[173]  P. Thomas,et al.  Classification, Differential Diagnosis, and Staging of Diabetic Peripheral Neuropathy , 1997, Diabetes.

[174]  Jeroen J. Bax,et al.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[175]  Ralph L. Sacco,et al.  American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 Update: A Scientific Statement for Public Health Practitioners, Healthcare Providers, and Health Policy Makers , 2013, Circulation.

[176]  Rodica Pop-Busui,et al.  Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial , 2010, The Lancet.

[177]  K. Gadde,et al.  Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study , 2011, The American journal of clinical nutrition.

[178]  J. Halter,et al.  Abnormal Insulin Secretion, Not Insulin Resistance, Is the Genetic or Primary Defect of MODY in the RW Pedigree , 1994, Diabetes.

[179]  Limin Peng,et al.  Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery) , 2011, Diabetes Care.

[180]  P. Touboul,et al.  Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis , 2011, Journal of cardiovascular pharmacology.

[181]  C. Schmid,et al.  Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. , 2005, The Cochrane database of systematic reviews.

[182]  M. Chien,et al.  Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta‐analysis , 2012, Diabetes, obesity & metabolism.

[183]  D. Whiteman,et al.  Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. , 2007, European journal of cancer.

[184]  E. Haddad,et al.  Meats, Processed Meats, Obesity, Weight Gain and Occurrence of Diabetes among Adults: Findings from Adventist Health Studies , 2008, Annals of Nutrition and Metabolism.

[185]  Mohammad Hassan Murad,et al.  Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. , 2012, The Journal of clinical endocrinology and metabolism.

[186]  J. L. Botha,et al.  Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes , 1997, Epidemiology and Infection.

[187]  G. Viberti Thiazolidinediones-benefits on microvascular complications of type 2 diabetes. , 2005, Journal of diabetes and its complications.

[188]  D. Ryan,et al.  Weight-Loss Therapy in Type 2 Diabetes: Effects of Phentermine and Topiramate Extended Release , 2014, Diabetes Care.

[189]  John H Fuller,et al.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.

[190]  Benjamin Cheong,et al.  Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. , 2002, Diabetes care.

[191]  S. Shott,et al.  Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. , 2005, Archives of internal medicine.

[192]  James D Dziura,et al.  Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. , 2004, Diabetes care.

[193]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[194]  M. Freemark,et al.  Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. , 2002, The Journal of pediatrics.

[195]  J. Ge,et al.  Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis. , 2010, Diabetes research and clinical practice.

[196]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[197]  M. Hanefeld,et al.  Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. , 1999, Diabetes care.

[198]  S. McClave,et al.  Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). , 2009, JPEN. Journal of parenteral and enteral nutrition.

[199]  J. Ballenger Antidepressants and Body Weight: A Comprehensive Review and Meta-Analysis , 2012 .

[200]  E. Jude,et al.  Managing complications of the diabetic foot , 2009, BMJ : British Medical Journal.

[201]  R. Henry,et al.  Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release , 2014, Diabetes Care.

[202]  B. Shields,et al.  Insulin Mutation Screening in 1,044 Patients With Diabetes , 2008, Diabetes.

[203]  William S. Yancy,et al.  Nutrition Therapy Recommendations for the Management of Adults With Diabetes , 2013, Diabetes Care.

[204]  J. Saver,et al.  Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis. , 2011, Atherosclerosis.

[205]  Jiaquan Xu,et al.  Deaths: final data for 2006. , 2009, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[206]  R. Goldbohm,et al.  Height, Body Mass Index, and Ovarian Cancer: A Pooled Analysis of 12 Cohort Studies , 2008, Cancer Epidemiology Biomarkers & Prevention.

[207]  A. Vinik,et al.  Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease , 2013, Journal of diabetes investigation.

[208]  Edward M. Hitchcock,et al.  Obesity and other risk factors: the national survey of U.S. long-haul truck driver health and injury. , 2014, American journal of industrial medicine.

[209]  B. Charbonnel,et al.  Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin , 2012, Current medical research and opinion.

[210]  Michael Mauer,et al.  Histopathology of diabetic nephropathy. , 2007, Seminars in nephrology.

[211]  J. Valls-Solé,et al.  European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe‐deration of Neurological Societies and the Peripheral Nerve Society , 2010, European journal of neurology.

[212]  Diederick Grobbee,et al.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.

[213]  J. Stamler Clofibrate and niacin in coronary heart disease. , 1975, JAMA.

[214]  Dennis D. Kim,et al.  Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. , 2005, Diabetes care.

[215]  R. Toto,et al.  Hypertension in patients with diabetes , 2000, Postgraduate medicine.

[216]  Walter T Ambrosius,et al.  Effects of medical therapies on retinopathy progression in type 2 diabetes. , 2010, The New England journal of medicine.

[217]  P. Sönksen,et al.  A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population , 1993, Diabetologia.

[218]  P. Mitchell,et al.  Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial , 2007, The Lancet.

[219]  A. Vinik,et al.  Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia. , 2014, Pain medicine.

[220]  J. Pirart Why Don't We Teach and Treat Diabetic Patients Better? , 1978, Diabetes Care.

[221]  N. Wenger,et al.  Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly [ZETELD] study). , 2010, The American journal of cardiology.

[222]  F. Sacks,et al.  Combination lipid therapy in type 2 diabetes. , 2010, The New England journal of medicine.

[223]  Mary T Korytkowski,et al.  Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. , 2012, The Journal of clinical endocrinology and metabolism.

[224]  P. Froguel,et al.  Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes. , 2008, Endocrine reviews.

[225]  Sheri R. Colberg,et al.  Balance Training Reduces Falls Risk in Older Individuals With Type 2 Diabetes , 2010, Diabetes Care.

[226]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[227]  J. Christiansen,et al.  Overnight CSII as supplement to oral antidiabetic drugs in Type 2 diabetes , 2008, Diabetes, obesity & metabolism.

[228]  L. Jovanovič,et al.  Frequent Monitoring of A1C During Pregnancy as a Treatment Tool to Guide Therapy , 2010, Diabetes Care.

[229]  S. Heller,et al.  Maternal Glycemic Control and Hypoglycemia in Type 1 Diabetic Pregnancy , 2007, Diabetes Care.

[230]  A. Vinik A medicinal food provides food for thought in managing diabetic neuropathy. , 2013, The American journal of medicine.

[231]  J. Tamsma,et al.  Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.

[232]  C. Goldsmith,et al.  A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events , 2007, Diabetes Care.

[233]  I. Harman-boehm,et al.  Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[234]  S. Johnson,et al.  A longitudinal analysis of adherence and health status in childhood diabetes. , 1992, Journal of pediatric psychology.

[235]  Vivian A Fonseca,et al.  Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence , 2010, Diabetes, obesity & metabolism.

[236]  D. Sandman,et al.  A focused exercise regimen improves clinical measures of balance in patients with peripheral neuropathy. , 2001, Archives of physical medicine and rehabilitation.

[237]  F. Ashcroft,et al.  Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. , 2004, The New England journal of medicine.

[238]  Anahit Mehrabyan,et al.  Diagnosis and management of diabetic autonomic neuropathy , 2003, Comprehensive therapy.

[239]  E. Eugster,et al.  Position Statement: Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes , 2006, Pediatrics.

[240]  J. Adamson,et al.  KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease , 2012 .

[241]  J. Callés-Escandon,et al.  Increased Glycemic Variability Is Independently Associated With Length of Stay and Mortality in Noncritically Ill Hospitalized Patients , 2013, Diabetes Care.

[242]  B. Heitmann,et al.  Should glycemic index and glycemic load be considered in dietary recommendations? , 2008, Nutrition reviews.

[243]  K. Hemminki,et al.  The impact of type 2 diabetes mellitus on cancer‐specific survival , 2012, Cancer.

[244]  B. Mokhlesi,et al.  The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea , 2005, Sleep and Breathing.

[245]  J. Leahy A Double-Blind, Placebo-Controlled Trial Assessing Pramlintide Treatment in the Setting of Intensive Insulin Therapy in Type 1 Diabetes , 2007 .

[246]  A. Stagnaro-Green,et al.  Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia. , 1995, The Mount Sinai journal of medicine, New York.

[247]  T. Kasai,et al.  Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. , 2008, Chest.

[248]  F. Greenway,et al.  Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes , 2013, Diabetes Care.

[249]  A. Vinik,et al.  Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.

[250]  J. Lupski,et al.  Practice Parameter: The Evaluation of Distal Symmetric Polyneuropathy: The Role of Autonomic Testing, Nerve Biopsy, and Skin Biopsy (An Evidence‐Based Review) , 2009, PM & R : the journal of injury, function, and rehabilitation.

[251]  R. Aronson,et al.  Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial , 2014, The Lancet.

[252]  N. Day,et al.  Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk , 2004, Annals of Internal Medicine.

[253]  Yogish C Kudva,et al.  Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. , 2009, The Journal of clinical endocrinology and metabolism.

[254]  A. Rissanen,et al.  Predictive value of early weight loss in obesity management with orlistat: an evidence-based assessment of prescribing guidelines , 2003, International Journal of Obesity.

[255]  E. Braunwald,et al.  Coronary heart disease Acute coronary syndromes and diabetes : is intensive lipid lowering beneficial ? Results of the PROVE IT-TIMI 22 trial , 2006 .

[256]  A. R. Mangels,et al.  Position of the American Dietetic Association: vegetarian diets. , 2009, Journal of the American Dietetic Association.

[257]  J. McGill,et al.  Diabetes and cancer--an AACE/ACE consensus statement. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[258]  R. Scharfmann,et al.  Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. , 2006, The New England journal of medicine.

[259]  A. Vinik,et al.  Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes , 2010, Diabetes, metabolic syndrome and obesity : targets and therapy.

[260]  Ian J. Deary,et al.  Severe Hypoglycemia and Cognitive Decline in Older People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study , 2014, Diabetes Care.

[261]  J. Foody,et al.  Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study). , 2010, The American journal of cardiology.

[262]  Hyuni Lee,et al.  Improvement of cardiovascular risk factors in patients with type 2 diabetes after long‐term continuous subcutaneous insulin infusion , 2008, Diabetes/metabolism research and reviews.

[263]  D. Muchmore,et al.  Use of recombinant human hyaluronidase to accelerate rapid insulin analogue absorption: experience with subcutaneous injection and continuous infusion. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[264]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. , 2009, Lancet.

[265]  Winfried März,et al.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005 .

[266]  Michael Larsen,et al.  Diabetic retinopathy screening using digital non-mydriatic fundus photography and automated image analysis. , 2004, Acta ophthalmologica Scandinavica.

[267]  G. Moneta,et al.  Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein , 2009 .

[268]  A. Vinik,et al.  Pioglitazone treatment improves nitrosative stress in type 2 diabetes. , 2006, Diabetes care.

[269]  P. Bennett,et al.  Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. , 1990, Diabetes/metabolism reviews.

[270]  R. Freeman,et al.  Diabetic autonomic neuropathy. , 2003, Diabetes care.

[271]  Preventive cardiologyAbstractsComparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: A randomized trial , 2005 .

[272]  R. Freeman,et al.  Treatment‐induced diabetic neuropathy: A reversible painful autonomic neuropathy , 2010, Annals of neurology.

[273]  J. Dorca,et al.  Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia. , 2014, The Journal of infection.

[274]  D. Leroith,et al.  Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. , 2010, Cancer research.

[275]  G. Cruccu,et al.  Tools for Assessing Neuropathic Pain , 2009, PLoS medicine.

[276]  Andrew J.M. Boulton,et al.  Neuropathic Diabetic Foot Ulcers , 2004 .

[277]  G. Ning,et al.  Diabetes and cancer relationships (糖尿病与肿瘤的关联性) , 2013, Journal of diabetes.

[278]  S. Dagogo-Jack Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum , 2010, Nature Reviews Endocrinology.

[279]  M. Phillip,et al.  Use of Insulin Pump Therapy in the Pediatric Age-Group , 2007, Diabetes Care.

[280]  J. Murray A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial , 2012 .

[281]  H. Kuipers,et al.  Influence of acute exercise on hyperglycemia in insulin-treated type 2 diabetes. , 2006, Medicine and science in sports and exercise.

[282]  A. Cherrington,et al.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. , 2012, The Journal of clinical investigation.

[283]  Dariush Mozaffarian,et al.  Red and Processed Meat Consumption and Risk of Incident Coronary Heart Disease, Stroke, and Diabetes Mellitus: A Systematic Review and Meta-Analysis , 2010, Circulation.

[284]  R. Bergenstal,et al.  Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea. , 2009, Current medical research and opinion.

[285]  J. Sturis,et al.  Combination of the insulin sensitizer, pioglitazone, and the long‐acting GLP‐1 human analog, liraglutide, exerts potent synergistic glucose‐lowering efficacy in severely diabetic ZDF rats , 2008, Diabetes, obesity & metabolism.

[286]  R. Vigersky,et al.  Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society , 2013, Diabetes Care.

[287]  G. Bray,et al.  Medical Therapy for the Patient With Obesity , 2012, Circulation.

[288]  L. Heinemann,et al.  Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study , 2011, Diabetologia.

[289]  F. Ashcroft,et al.  Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. , 2006, The New England journal of medicine.

[290]  A. Donker,et al.  Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial , 2010, BMJ : British Medical Journal.

[291]  O. Ober Diabetes Prevention Program , 2012 .

[292]  Do Peterson,et al.  Collaborative care for patients with depression and chronic illnesses. , 2010, The New England journal of medicine.

[293]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[294]  J. Tuomilehto,et al.  Cardiovascular Disease Mortality in Europeans in Relation to Fasting and 2-h Plasma Glucose Levels Within a Normoglycemic Range , 2010, Diabetes Care.

[295]  R. Freeman,et al.  Diabetic Neuropathy , 2010, Diabetes Care.

[296]  Richard Hellman,et al.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[297]  D. Ryan,et al.  Prediction of response to sibutramine therapy in obese non‐diabetic and diabetic patients , 2006, Diabetes, obesity & metabolism.

[298]  V. Mohan,et al.  Moving to an A1C-Based Diagnosis of Diabetes Has a Different Impact on Prevalence in Different Ethnic Groups , 2009, Diabetes Care.

[299]  G. Bray,et al.  Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. , 2013, The New England journal of medicine.

[300]  Nish Chaturvedi,et al.  Cardiorenal end points in a trial of aliskiren for type 2 diabetes. , 2012, The New England journal of medicine.

[301]  R. Hughes,et al.  Duloxetine for treating painful neuropathy or chronic pain. , 2009, The Cochrane database of systematic reviews.

[302]  入江 潤一郎,et al.  Glucose control and vascular complications in veterans with type 2 diabetes , 2009 .

[303]  B. Hummer,et al.  Pancreatic safety of incretin-based drugs--FDA and EMA assessment. , 2014, The New England journal of medicine.

[304]  C. O'connor,et al.  Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes , 2010, Diabetes Care.

[305]  Dennis D. Kim,et al.  The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes , 2007, Annals of Internal Medicine.

[306]  T. Nurmikko,et al.  EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision , 2010, European journal of neurology.

[307]  Markku Peltonen,et al.  Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery , 2004 .

[308]  R. Plodkowski,et al.  Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists/the American College of Endocrinology and the Obesity Society: executive summary. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[309]  W. Ambrosius,et al.  Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial , 2010, Diabetes Care.

[310]  Bengt Persson,et al.  International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy , 2010, Diabetes Care.

[311]  Nancy R Cook,et al.  Statins: new American guidelines for prevention of cardiovascular disease , 2013, The Lancet.

[312]  J. Talbot,et al.  Randomized Trial Comparing Continuous Subcutaneous Insulin Infusion and Conventional Insulin Therapy in Type II Diabetic Patients Poorly Controlled With Sulfonylureas , 1991, Diabetes Care.

[313]  M. Hamburg,et al.  Regulatory action on rosiglitazone by the U.S. Food and Drug Administration. , 2010, The New England journal of medicine.

[314]  G. Van den Berghe,et al.  Glucose Variability and Mortality in Patients Hospitalized With Acute Myocardial Infarction , 2012, Circulation. Cardiovascular quality and outcomes.

[315]  A. Minder,et al.  Frequency of blood glucose testing in well educated patients with diabetes mellitus type 1: how often is enough? , 2013, Diabetes research and clinical practice.

[316]  R. Ness-Abramof Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study , 2010 .

[317]  S. Colagiuri,et al.  Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU) , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[318]  F. Rubino,et al.  Bariatric surgery: an IDF statement for obese Type 2 diabetes , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[319]  P. Wilson,et al.  The epidemiology of impaired glucose tolerance and hypertension. , 1991, American heart journal.

[320]  O G Kolterman,et al.  Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year, randomized controlled trial , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[321]  Thomas Penzel,et al.  Effect of Nasal Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients With Obstructive Sleep Apnea , 2003, Circulation.

[322]  T. Marrie,et al.  Admission hypoglycemia and increased mortality in patients hospitalized with pneumonia. , 2010, The American journal of medicine.

[323]  E. Feldman,et al.  Evidence-based guideline: Treatment of painful diabetic neuropathy , 2011, Neurology.

[324]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[325]  G. Moneta,et al.  Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes , 2007 .

[326]  M. Zwahlen,et al.  Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[327]  A. Vinik,et al.  Neuropathy: The Crystal Ball for Cardiovascular Disease? , 2010, Diabetes Care.

[328]  A. Nicolucci,et al.  Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES). , 2010, Archives of internal medicine.

[329]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[330]  An Pan,et al.  Increased mortality risk in women with depression and diabetes mellitus. , 2011, Archives of general psychiatry.

[331]  Ray Burke,et al.  A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. , 2005, Diabetes care.

[332]  A. Vinik,et al.  Small fiber neuropathy is associated with the metabolic syndrome. , 2005, Metabolic syndrome and related disorders.

[333]  D. Klonoff,et al.  Threshold-based insulin-pump interruption for reduction of hypoglycemia. , 2013, The New England journal of medicine.

[334]  Daniel W. Jones,et al.  Seventh report of the joint national committee on the prevention, detection, evaluation, and treatment of high blood pressure (JNC 7): Resetting the hypertension sails , 2003 .

[335]  P. Peduzzi,et al.  Combined angiotensin inhibition for the treatment of diabetic nephropathy. , 2013, The New England journal of medicine.

[336]  B. Goldstein,et al.  Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies , 2013, Diabetes Therapy.

[337]  R. Schlienger,et al.  Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK – a nested case–control analysis , 2014, Diabetes, obesity & metabolism.

[338]  A. Kitabchi,et al.  Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2002, The Journal of clinical endocrinology and metabolism.

[339]  S. Redline,et al.  Polysomnographic and health-related quality of life correlates of restless legs syndrome in the Sleep Heart Health Study. , 2009, Sleep.

[340]  S. Tunis,et al.  Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in Canada , 2010, Applied health economics and health policy.

[341]  Craig I Coleman,et al.  Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. , 2010, JAMA.

[342]  M. Fiatarone,et al.  Effects of High-Intensity Strength Training on Multiple Risk Factors for Osteoporotic Fractures: A Randomized Controlled Trial , 1994 .

[343]  B. Zinman,et al.  Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. , 2006, The New England journal of medicine.

[344]  C. Whitney,et al.  Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2014, MMWR. Morbidity and mortality weekly report.

[345]  Deepak L. Bhatt,et al.  Bariatric surgery versus intensive medical therapy in obese patients with diabetes. , 2012, The New England journal of medicine.

[346]  Alicja Wolk,et al.  Diabetes mellitus and risk of breast cancer: A meta‐analysis , 2007, International journal of cancer.

[347]  H. Tritschler,et al.  Effects of 3‐week oral treatment with the antioxidant thioctic acid (α‐lipoic acid) in symptomatic diabetic polyneuropathy , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[348]  J. Hsia,et al.  Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes , 2006, Diabetes Care.

[349]  John D. Clark,et al.  Food label use and awareness of nutritional information and recommendations among persons with chronic disease. , 2009, The American journal of clinical nutrition.

[350]  T. Wilt,et al.  Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: a systematic review for a KDOQI clinical practice guideline. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[351]  C. Rock,et al.  Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial , 2011, Obesity.

[352]  D. Mikhailidis,et al.  Early Benefit from Structured Care with Atorvastatin in Patients with Coronary Heart Disease and Diabetes Mellitus , 2003, Angiology.

[353]  P Glasziou,et al.  Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial , 2005, The Lancet.

[354]  L. Svetkey,et al.  Patient characteristics associated with receipt of lifestyle behavior advice. , 2009, North Carolina medical journal.

[355]  E. Giovannucci,et al.  A Meta-analysis of Diabetes Mellitus and the Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[356]  K. Schulman,et al.  STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects. , 2010, Diabetes technology & therapeutics.

[357]  Po Box,et al.  Excess risk of fatal coronary heart disease associated with diabetes in men and women:meta-analysis of 37 prospective cohort studies , 2006 .

[358]  Teven,et al.  MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .

[359]  N. Chaturvedi,et al.  Glycemic control and all-cause mortality risk in type 1 diabetes patients: the EURODIAB prospective complications study. , 2014, The Journal of clinical endocrinology and metabolism.

[360]  Michael E. Miller,et al.  Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.

[361]  R. Meeusen,et al.  Continuous low- to moderate-intensity exercise training is as effective as moderate- to high-intensity exercise training at lowering blood HbA1c in obese type 2 diabetes patients , 2009, Diabetologia.

[362]  M. Bromberg,et al.  Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. , 2001, Diabetes care.

[363]  D. Braun,et al.  A cohort study of acute pancreatitis in relation to exenatide use , 2011, Diabetes, obesity & metabolism.

[364]  S. Inzucchi,et al.  Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379 , 2013, Diabetes Care.

[365]  M. Stumvoll,et al.  Avoidance of Hypoglycemia Restores Hypoglycemia Awareness by Increasing -Adrenergic Sensitivity in Type 1 Diabetes , 2001, Annals of Internal Medicine.

[366]  Dan Ziegler,et al.  Diabetic neuropathies: a statement by the American Diabetes Association. , 2005, Diabetes care.

[367]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[368]  P. Ridker,et al.  An assessment by the Statin Diabetes Safety Task Force: 2014 update. , 2014, Journal of clinical lipidology.

[369]  T. Trinidad,et al.  The potential health benefits of legumes as a good source of dietary fibre , 2009, British Journal of Nutrition.

[370]  N. Levinsky Specialist Evaluation in Chronic Kidney Disease: Too Little, Too Late , 2002, Annals of Internal Medicine.

[371]  Alex J Sutton,et al.  Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data , 2011, BMJ : British Medical Journal.

[372]  L. Jovanovic-Peterson Medical Management of Pregnancy Complicated by Diabetes , 2009 .

[373]  K. Gadde,et al.  Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) , 2011, Obesity.

[374]  Rolf Rossaint,et al.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.

[375]  S. Kumar,et al.  Triple oral fixed‐dose diabetes polypill versus insulin plus metformin efficacy demonstration study in the treatment of advanced type 2 diabetes (TrIED study‐II) , 2011, Diabetes, obesity & metabolism.

[376]  C. Gieger,et al.  Replication of restless legs syndrome loci in three European populations , 2009, Journal of Medical Genetics.

[377]  Bruce W Bode,et al.  Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[378]  L. Sciacca,et al.  Use of insulin detemir during pregnancy. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[379]  Lawrence A Leiter,et al.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines , 2006, Current opinion in cardiology.

[380]  U. Munzel,et al.  Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy , 2006, Diabetes Care.

[381]  Eva L Feldman,et al.  Diabetic neuropathy: clinical manifestations and current treatments , 2012, The Lancet Neurology.

[382]  J. Dillinger,et al.  Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease. , 2012, American heart journal.

[383]  S. Redline,et al.  A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. , 2012, Sleep.

[384]  T. Wadden,et al.  Weight and Metabolic Outcomes After 2 Years on a Low-Carbohydrate Versus Low-Fat Diet , 2010, Annals of Internal Medicine.

[385]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[386]  Rayaz A. Malik,et al.  Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.

[387]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[388]  A. Vinik,et al.  Recognizing and treating diabetic autonomic neuropathy. , 2001, Cleveland Clinic journal of medicine.

[389]  R. Horwitz,et al.  Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia. , 2014, The American journal of medicine.

[390]  T. Gislason,et al.  Role of snoring and daytime sleepiness in occupational accidents. , 2001, American journal of respiratory and critical care medicine.

[391]  P. Marik,et al.  Original ResearchCritical Care MedicineToward Understanding Tight Glycemic Control in the ICU: A Systematic Review and Metaanalysis , 2010 .

[392]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[393]  S. Norris,et al.  Efficacy and Harms of the Hypoglycemic Agent Pramlintide in Diabetes Mellitus , 2010, The Annals of Family Medicine.

[394]  B. Kavanagh,et al.  Clinical practice. Glycemic control in the ICU. , 2010, The New England journal of medicine.

[395]  Michael E. Miller,et al.  Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes , 2011 .

[396]  R. Hanson,et al.  Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. , 2000, Diabetes.

[397]  Kristian Thorlund,et al.  Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. , 2014, JAMA.

[398]  E. Cummins,et al.  Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. , 2010, Health technology assessment.

[399]  Kenneth L. Jones,et al.  Medical writer , 2019, Combatting Burnout.

[400]  P. Quigley,et al.  Effect of a group-based exercise program on balance in elderly , 2007, Clinical interventions in aging.

[401]  G. Bakris,et al.  Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga , 2014, Diabetes Care.

[402]  A. Tighe,et al.  Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications , 2008, Expert review of cardiovascular therapy.

[403]  A. Keech,et al.  Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome , 2008, Diabetes Care.

[404]  J. Sowers,et al.  Hypertension in patients with diabetes , 2000, Postgraduate medicine.

[405]  Shari Bolen,et al.  Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus , 2007, Annals of Internal Medicine.

[406]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[407]  Anthony Delaney,et al.  Benefits and Risks of Tight Glucose Control in Critically Ill Adults: A Metaanalysis , 2009 .

[408]  J. Weissberg-Benchell,et al.  Insulin pump therapy: a meta-analysis. , 2003, Diabetes care.

[409]  Robert A Greevy,et al.  Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus , 2012, Annals of Internal Medicine.

[410]  O. Axelson,et al.  Mortality among taxi drivers in Rome: a cohort study. , 1994, American journal of industrial medicine.

[411]  A. Berghold,et al.  Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[412]  Daniel B. Jones,et al.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. , 2013, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[413]  A. Vinik,et al.  Exercise improves gait, reaction time and postural stability in older adults with type 2 diabetes and neuropathy. , 2014, Journal of diabetes and its complications.

[414]  G. Grunkemeier,et al.  Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.

[415]  S. Roze,et al.  Health‐economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK , 2005 .

[416]  A. Minihane,et al.  Impact of Oil used by the Frying Industry on Population Fat Intake , 2007, Critical reviews in food science and nutrition.

[417]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[418]  F. Chan,et al.  Cardiovascular Diabetology BioMed Central Original investigation , 1995 .

[419]  M. Rowley,et al.  GAD Antibody Negative NIDDM in Adult Black Subjects with Diabetic Ketoacidosis and Increased Frequency of Human Leukocyte Antigen DR3 and DR4: Flatbush Diabetes , 1994, Diabetes.

[420]  G. Virgili,et al.  Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. , 2009, The Cochrane database of systematic reviews.

[421]  S. Toubro,et al.  Effect of Orlistat on Weight Regain and Cardiovascular Risk Factors Following a Very-Low-Energy Diet in Abdominally Obese Patients , 2007, Diabetes Care.

[422]  E. Barrett,et al.  Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. , 2009, JAMA.

[423]  Diane M. Miller,et al.  Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in Diabetes Patients With Cardiovascular History Trial , 2010, Circulation.

[424]  Craig Wilson,et al.  Alogliptin after acute coronary syndrome in patients with type 2 diabetes. , 2013, The New England journal of medicine.

[425]  D. Riche,et al.  Thiazolidinediones and Risk of Repeat Target Vessel Revascularization Following Percutaneous Coronary Intervention , 2007, Diabetes Care.

[426]  M. Minshall,et al.  A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspective. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[427]  J. Mechanick,et al.  American Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticals. , 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[428]  D. Makris,et al.  Diabetes and Hemoglobin A1c as Risk Factors for Nosocomial Infections in Critically Ill Patients , 2013, Critical care research and practice.

[429]  Roberto Ferrari,et al.  The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. , 2004, European heart journal.

[430]  S. Inzucchi,et al.  Clinical practice. Management of hyperglycemia in the hospital setting. , 2006, The New England journal of medicine.

[431]  Guillermo,et al.  Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes A pilot, randomized, controlled study , 2022 .

[432]  A. Lewiński,et al.  Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[433]  Z. Bloomgarden,et al.  What role will 'gliptins' play in glycemic control? , 2008, Cleveland Clinic journal of medicine.

[434]  S. Freedland,et al.  Obesity and prostate cancer: weighing the evidence. , 2013, European urology.

[435]  L. Zelek,et al.  Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies , 2012, Breast Cancer Research and Treatment.

[436]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[437]  P. Bennett,et al.  Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. , 1983, The New England journal of medicine.

[438]  G. Moneta Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial , 2009 .

[439]  P. Knight Principles and Practice of Geriatric Medicine , 1987 .

[440]  Lizheng Shi,et al.  Economic burden of hypoglycemia in patients with Type 2 diabetes , 2012, Expert review of pharmacoeconomics & outcomes research.

[441]  J. Arezzo,et al.  Diabetic somatic neuropathies. , 2004, Diabetes care.

[442]  J. Stradling,et al.  Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes , 2007, Thorax.

[443]  A. Vinik,et al.  Contact heat-evoked potential stimulation for the evaluation of small nerve fiber function. , 2013, Diabetes technology & therapeutics.

[444]  D. Wade,et al.  The natural history of acute painful neuropathy in diabetes mellitus. , 1983, Journal of neurology, neurosurgery, and psychiatry.

[445]  N. Shah,et al.  Increased Mortality of Patients With Diabetes Reporting Severe Hypoglycemia , 2012, Diabetes Care.

[446]  Stephen O’Riordana,et al.  Insulin mutation screening in 1 , 044 patients with diabetes : mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood , 2008 .

[447]  A. Goto,et al.  Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis , 2013, BMJ.

[448]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[449]  Claude Bouchard,et al.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. , 2004, The New England journal of medicine.

[450]  L. Sjöström,et al.  XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. , 2004, Diabetes care.

[451]  D. Maahs,et al.  ISPAD Clinical Practice Consensus Guidelines 2014 Compendium , 2014 .

[452]  J. Fain Diabetes Prevention Program: Education is Vital , 2002, The Diabetes educator.

[453]  R. Freeman,et al.  Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy , 2011, Diabetes Care.

[454]  T. Larson,et al.  Modeling Chronic Glycemic Exposure Variables as Correlates and Predictors of Microvascular Complications of Diabetes , 2007, Diabetes Care.

[455]  L. Groop,et al.  Screening for MODY mutations, GAD antibodies, and type 1 diabetes--associated HLA genotypes in women with gestational diabetes mellitus. , 2002, Diabetes care.

[456]  M. Mendu,et al.  Diabetes mellitus and community-acquired bloodstream infections in the critically ill. , 2014, Journal of critical care.

[457]  K. Nørgaard,et al.  [Cost-effectiveness of continuous subcutaneous insulin infusion therapy for type 1 diabetes]. , 2010, Ugeskrift for laeger.

[458]  B. Yeap,et al.  Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study , 2008, Diabetologia.

[459]  H. Krumholz,et al.  Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. , 2009, JAMA.

[460]  D. Hillman,et al.  Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea. , 2012, The Journal of clinical endocrinology and metabolism.

[461]  A. Vinik,et al.  Relation between risk of falling and postural sway complexity in diabetes. , 2012, Gait & posture.

[462]  R. Haring,et al.  Surgical therapy of hyperinsulinism , 1981, World Journal of Surgery.

[463]  D. Rybin,et al.  Weight-Based, Insulin Dose–Related Hypoglycemia in Hospitalized Patients With Diabetes , 2011, Diabetes Care.

[464]  P. Cryer Death during intensive glycemic therapy of diabetes: mechanisms and implications. , 2011, The American journal of medicine.

[465]  J. Lecerf,et al.  A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. , 2010, The American journal of clinical nutrition.

[466]  R. Pettis,et al.  Microneedle delivery: clinical studies and emerging medical applications. , 2012, Therapeutic delivery.

[467]  M. Hanefeld,et al.  The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo‐controlled trial , 2002, Diabetes, obesity & metabolism.

[468]  G. Umpierrez,et al.  Risk Factors for Inpatient Hypoglycemia during Subcutaneous Insulin Therapy in Non-Critically Ill Patients with Type 2 Diabetes , 2012, Journal of diabetes science and technology.

[469]  P. Toth Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy: A Meta-analysis , 2012 .

[470]  J. N. Fisher,et al.  Hyperglycemic Crises in Adult Patients With Diabetes , 2009, Diabetes Care.

[471]  O. Ganda Dyslipidemia: Pathogenesis and Management , 2010 .

[472]  David D. Dore,et al.  Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide , 2009, Current medical research and opinion.

[473]  R. Collins,et al.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[474]  M. Pendergrass,et al.  Acute Pancreatitis in Type 2 Diabetes Treated With Exenatide or Sitagliptin , 2010, Diabetes Care.

[475]  D. Suh,et al.  Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988–2004 , 2009, Journal of hypertension.

[476]  A. Jenkins,et al.  Feasibility of Adjacent Insulin Infusion and Continuous Glucose Monitoring via the Medtronic Combo-Set , 2013, Journal of diabetes science and technology.

[477]  A. Vinik,et al.  Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. , 2013, Diabetes technology & therapeutics.

[478]  J. Olson,et al.  Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme , 2013, Diabetologia.

[479]  G. Umpierrez,et al.  PHARMACOLOGIC TREATMENT OF TYPE 2 DIABETES ( AVELLA , SECTION EDITOR ) Sulfonylureas : A New Look at Old Therapy , 2014 .

[480]  F. Sacks,et al.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. , 2012, The Journal of clinical endocrinology and metabolism.

[481]  C. Whitney,et al.  Use of 13‐Valent Pneumococcal Conjugate Vaccine and 23‐Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2013, MMWR. Morbidity and mortality weekly report.

[482]  J. Ochoa,et al.  NEUROPATHIC PAIN: REDEFINITION AND A GRADING SYSTEM FOR CLINICAL AND RESEARCH PURPOSES , 2009, Neurology.

[483]  J. Rosenstock,et al.  Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. , 2013, The American journal of medicine.

[484]  T. Gardner,et al.  Predicting Development of Proliferative Diabetic Retinopathy , 2013, Diabetes Care.

[485]  R. Little,et al.  Measurement of Hba(1C) in patients with chronic renal failure. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[486]  C. Rosebraugh,et al.  Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy. , 2010, The New England journal of medicine.

[487]  Dennis D. Kim,et al.  A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-related Risk Factors (COR-II) , 2013, Obesity.

[488]  L. Jovanovic,et al.  Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes , 2011, Diabetes/metabolism research and reviews.

[489]  H. Fields,et al.  Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials , 2001, Journal of the Neurological Sciences.

[490]  H. Krumholz,et al.  Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction: Implications for Patients With and Without Recognized Diabetes , 2005, Circulation.

[491]  John B Buse,et al.  Effects of combination lipid therapy in type 2 diabetes mellitus. , 2010, The New England journal of medicine.

[492]  J. Forrester,et al.  Epidemiology of diabetic retinopathy and macular oedema: a systematic review , 2004, Eye.

[493]  A. Boulton,et al.  Mechanisms and Management of Diabetic Painful Distal Symmetrical Polyneuropathy , 2013, Diabetes Care.

[494]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[495]  Jackson T. Wright,et al.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.

[496]  S. Kusunoki,et al.  Autoimmune mechanisms in peripheral neuropathies , 1990, Annals of neurology.

[497]  S. Mudaliar,et al.  Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. , 2003, Diabetes care.

[498]  Patrick J Heagerty,et al.  Temporal trends in the prevalence of diabetic kidney disease in the United States. , 2011, JAMA.

[499]  A. Vinik The approach to the management of the patient with neuropathic pain. , 2010, The Journal of clinical endocrinology and metabolism.

[500]  J. K. Radder,et al.  Course of HbA1c in non-diabetic pregnancy related to birth weight. , 2013, The Netherlands journal of medicine.

[501]  C Osmond,et al.  Fetal and infant growth and impaired glucose tolerance at age 64. , 1991, BMJ.

[502]  A. Thanopoulou,et al.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.

[503]  J. Assal,et al.  [Long-term complications in diabetes mellitus]. , 1989, Acta medica portuguesa.

[504]  Salim Yusuf,et al.  Basal insulin and cardiovascular and other outcomes in dysglycemia. , 2012, The New England journal of medicine.

[505]  Christopher T Sempos,et al.  Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. , 2006, The American journal of cardiology.

[506]  W. Rathmann,et al.  Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis. , 2014, Primary care diabetes.

[507]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[508]  Brenda R. Hemmelgarn,et al.  Notice , 2012, Kidney International Supplements.

[509]  S. Bowlin,et al.  Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. , 2009, Clinical therapeutics.

[510]  M. Tonelli,et al.  Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease , 2012, Annals of Internal Medicine.

[511]  A. Vaag,et al.  Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial , 2009, Diabetologia.

[512]  E. Horton,et al.  Exercise in the Management of Type 1 Diabetes Mellitus , 2003, Reviews in Endocrine and Metabolic Disorders.

[513]  R Peto,et al.  Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. , 2008, Lancet.

[514]  A. Astrup,et al.  Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide , 2011, International Journal of Obesity.

[515]  C. Bouchard,et al.  Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. , 2014, JAMA.

[516]  C. Kapitza,et al.  Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin , 2010, Diabetes Care.

[517]  J. Krinsley,et al.  Glycemic variability: A strong independent predictor of mortality in critically ill patients* , 2008, Critical care medicine.

[518]  A. Kriska,et al.  Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: From the Look AHEAD Study , 2013, Obesity.

[519]  Nish Chaturvedi,et al.  Vascular risk factors and diabetic neuropathy. , 2005, The New England journal of medicine.

[520]  Irl B Hirsch,et al.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[521]  R. Klein,et al.  Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.

[522]  Michael E. Miller,et al.  The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study , 2010, BMJ : British Medical Journal.

[523]  V. Vuksan,et al.  Fiber facts: Benefits and recommendations for individuals with type 2 diabetes , 2009, Current diabetes reports.

[524]  D. Bliwise,et al.  Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients. , 2000, Obesity research.

[525]  D. Yue,et al.  The relationship among pain, sensory loss, and small nerve fibers in diabetes. , 2006, Diabetes care.

[526]  B. Hemmelgarn,et al.  Anti-diabetic drug use and the risk of motor vehicle crash in the elderly. , 2006, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[527]  L. Niskanen,et al.  Depression and major weight gain: a 6-year prospective follow-up of outpatients. , 2013, Comprehensive psychiatry.

[528]  E. Stålberg,et al.  Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies , 2008, Journal of Neurology.

[529]  J. Rosenstock,et al.  Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets , 2012, Diabetes Care.

[530]  Bernard Friedman,et al.  Multiple hospitalizations for patients with diabetes. , 2003, Diabetes care.

[531]  A. Vaag,et al.  Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People , 2008, Circulation.

[532]  D. Bruttomesso,et al.  Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience , 2008, Acta Diabetologica.

[533]  A. Vinik,et al.  Diabetic neuropathy in older adults. , 2008, Clinics in geriatric medicine.

[534]  K. Mandroukas,et al.  Heart rate variability modifications following exercise training in type 2 diabetic patients with definite cardiac autonomic neuropathy , 2007, British Journal of Sports Medicine.

[535]  E. Lewis,et al.  Aliskiren combined with losartan in type 2 diabetes and nephropathy. , 2008, The New England journal of medicine.

[536]  M. Riddle,et al.  Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes , 2009, Diabetes Care.

[537]  Deepak L. Bhatt,et al.  Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. , 2013, The New England journal of medicine.

[538]  Loyd,et al.  SIMVASTATIN AND NIACIN , ANTIOXIDANT VITAMINS , OR THE COMBINATION FOR THE PREVENTION OF CORONARY DISEASE , 2001 .

[539]  A. Lincoff,et al.  Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. , 2007, JAMA.

[540]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[541]  F. Ovalle Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis , 2010 .

[542]  T. Davis,et al.  Aspirin Is Associated With Reduced Cardiovascular and All-Cause Mortality in Type 2 Diabetes in a Primary Prevention Setting , 2009, Diabetes Care.

[543]  A. Berghold,et al.  Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis , 2008, Diabetologia.

[544]  V. Messina,et al.  Position of the American Dietetic Association: Vegetarian Diets , 2022 .

[545]  I. Constable,et al.  Prevalence of Diabetic Complications in Relation to Risk Factors , 1986, Diabetes.

[546]  R. Henry,et al.  New options for the treatment of obesity and type 2 diabetes mellitus (narrative review). , 2013, Journal of diabetes and its complications.

[547]  A. Vinik,et al.  A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy , 2014, Diabetes Care.

[548]  A. Powell Two-year sustained weight loss and metabolic benefits with controlled-release Phentermine/Topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study , 2012 .

[549]  E. Sivan,et al.  Macrosomia in well controlled CSII treated Type I diabetic pregnancy , 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[550]  P. Valensi,et al.  A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. , 2005, Journal of diabetes and its complications.

[551]  Deepak L. Bhatt,et al.  Bariatric surgery versus intensive medical therapy in obese patients with diabetes. , 2012, The New England journal of medicine.

[552]  R. Asmar,et al.  Optimal nephroprotection: use, misuse and misconceptions about blockade of the renin-angiotensin system. Lessons from the ONTARGET and other recent trials. , 2009, Diabetes & metabolism.

[553]  G. R. Jackson,et al.  Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial. , 2014, JAMA ophthalmology.

[554]  A. Peltier,et al.  Painful diabetic neuropathy. , 2014, BMJ.

[555]  S. Studenski,et al.  Relationship Between Vitamin B12 and Sensory and Motor Peripheral Nerve Function in Older Adults , 2012, Journal of the American Geriatrics Society.

[556]  E. Masson,et al.  Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog) , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[557]  Tetsuro Tsujimoto,et al.  Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis , 2012, PloS one.

[558]  M. Massi-Benedetti,et al.  Meta‐analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine , 2010, Diabetes, obesity & metabolism.

[559]  R. Pawlak,et al.  Benefits, barriers, self-efficacy and knowledge regarding healthy foods; perception of African Americans living in eastern North Carolina , 2009, Nutrition research and practice.

[560]  G. V. Berghe,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[561]  P. Whelton,et al.  Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 2005 .

[562]  D. Matthews,et al.  Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach , 2012, Diabetes Care.

[563]  Therese Miller,et al.  Aspirin for the Primary Prevention of Cardiovascular Events , 2009 .

[564]  N. Marchionni,et al.  Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis. , 2008, Diabetes research and clinical practice.

[565]  R. Loomba,et al.  Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status , 2009, Advances in therapy.

[566]  N. Weissman,et al.  Multicenter, placebo-controlled trial of lorcaserin for weight management. , 2010, The New England journal of medicine.

[567]  P. Rosenblit Do Persons with Diabetes Benefit from Combination Statin and Fibrate Therapy? , 2012, Current Cardiology Reports.

[568]  Jennette P. Moreno,et al.  Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes , 2014, Current Atherosclerosis Reports.

[569]  P. Verdecchia,et al.  Prognostic value of ambulatory blood pressure : current evidence and clinical implications. , 2000, Hypertension.

[570]  Grant D. Huang,et al.  The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial. , 2011, Journal of diabetes and its complications.

[571]  John S Yudkin,et al.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.

[572]  Desmond E. Williams,et al.  Changes in diabetes-related complications in the United States, 1990-2010. , 2014, The New England journal of medicine.

[573]  Mark Woodward,et al.  Severe hypoglycemia and risks of vascular events and death. , 2010, The New England journal of medicine.

[574]  M. Bromberg,et al.  Painful sensory polyneuropathy associated with impaired glucose tolerance , 2001, Muscle & nerve.

[575]  R. Devine,et al.  Hypoglycemia: minimizing its impact in type 2 diabetes. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[576]  L. Martens,et al.  Costs and duration of care for lower extremity ulcers in patients with diabetes. , 1998, Clinical therapeutics.

[577]  F. Gueyffier,et al.  Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials , 2012, PLoS medicine.

[578]  J. Dostrovsky,et al.  Neuropathic pain , 2008, Neurology.

[579]  B. Zinman,et al.  The Effect of Excess Weight Gain With Intensive Diabetes Mellitus Treatment on Cardiovascular Disease Risk Factors and Atherosclerosis in Type 1 Diabetes Mellitus: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) Stu , 2013, Circulation.

[580]  E. Feskens,et al.  Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.

[581]  D. Pereg,et al.  Normal fasting plasma glucose levels and type 2 diabetes in young men. , 2005, The New England journal of medicine.

[582]  Robert J. Anderson,et al.  Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis , 2009, Diabetes.

[583]  Comparison of the Atkins, Zone, Ornish, and LEARN Diets for Change in Weight and Related Risk Factors Among Overweight Premenopausal Women: The A TO Z Weight Loss Study: A Randomized Trial , 2007 .

[584]  Steven A. Smith,et al.  Use of influenza and pneumococcal vaccines in people with diabetes. , 2000, Diabetes care.

[585]  D. Owens,et al.  Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study , 2013, BMJ Open.

[586]  Dennis D. Kim,et al.  Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. , 2005, Diabetes care.

[587]  F. Crea,et al.  COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment. , 2009, European heart journal.

[588]  L. Rydén,et al.  Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[589]  J. Lupski,et al.  Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review) , 2009, Neurology.

[590]  K. Jablonski,et al.  Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. , 2003, Diabetes care.

[591]  John Chalmers,et al.  Clinical Practice Guidelines for the Management of Hypertension in the Community , 2014, Journal of clinical hypertension.

[592]  D. Robbins,et al.  Diabetes : clinical science in practice , 1995 .

[593]  G. Umpierrez,et al.  Hospital Discharge Algorithm Based on Admission HbA1c for the Management of Patients With Type 2 Diabetes , 2014, Diabetes Care.

[594]  I. Hirsch,et al.  Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. , 2003, JAMA.

[595]  James W. Anderson,et al.  Grain Foods and Health: A Primer for Clinicians , 2008, The Physician and sportsmedicine.

[596]  A. Boulton,et al.  Role of Experimental Socks in the Care of the High-Risk Diabetic Foot: A multicenter patient evaluation study , 1993, Diabetes Care.

[597]  Bruce W Bode,et al.  Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. , 2005, Diabetes care.

[598]  L. Aronne,et al.  Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin. , 2002, Diabetes care.

[599]  J. Fleg,et al.  Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial , 2010, Diabetes Care.

[600]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[601]  B. J. Gersh Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials , 2011 .

[602]  A. Peters,et al.  Diabetes Care for Emerging Adults: Recommendations for Transition From Pediatric to Adult Diabetes Care Systems , 2011, Diabetes Care.

[603]  M. Noakes,et al.  Effect of carbohydrate distribution on postprandial glucose peaks with the use of continuous glucose monitoring in type 2 diabetes. , 2008, The American journal of clinical nutrition.

[604]  R. Plodkowski,et al.  Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists/the American College of Endocrinology and the Obesity Society. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[605]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[606]  J. Danesh,et al.  Major lipids, apolipoproteins, and risk of vascular disease. , 2009, JAMA.

[607]  Sarah Parish,et al.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.

[608]  T. Harrison Faculty Opinions recommendation of Lifestyle intervention for pre-diabetic neuropathy. , 2006 .

[609]  H. El‐Serag,et al.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[610]  T. Jacobson Overcoming ‘Ageism’ Bias in the Treatment of Hypercholesterolaemia , 2006, Drug safety.

[611]  J. McGill,et al.  Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants , 2013, Diabetes Care.

[612]  Limin Peng,et al.  Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes , 2013, Diabetes Care.

[613]  D. Bruttomesso,et al.  Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[614]  Jeffrey A. Cohen,et al.  Evidence‐based Guideline: Treatment of Painful Diabetic Neuropathy , 2011, PM & R : the journal of injury, function, and rehabilitation.

[615]  G. Pugliese,et al.  Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: a Meta-Analysis , 2007, Diabetes Care.

[616]  M. Spüler,et al.  The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. , 1992, Journal of diabetes and its complications.

[617]  L. Grohskopf,et al.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season , 2014, MMWR. Morbidity and mortality weekly report.

[618]  J. Rosenbauer,et al.  Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes , 2011, Pediatric diabetes.

[619]  Claude Lenfant,et al.  Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. , 2003, Hypertension.

[620]  H. Gharib,et al.  American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines--2010 update. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[621]  E. Rimm,et al.  Body mass index and risk of prostate cancer in U.S. health professionals. , 2003, Journal of the National Cancer Institute.

[622]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[623]  Nathan Efron,et al.  Surrogate Markers of Small Fiber Damage in Human Diabetic Neuropathy , 2007, Diabetes.

[624]  Z. Al-Aly,et al.  Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[625]  W. Tamborlane,et al.  Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device , 2012, Pediatric diabetes.

[626]  S. Boutreux,et al.  Effectiveness of Intensive Insulin Therapy by Multiple Daily Injections and Continuous Subcutaneous Infusion: A Comparison Study in Type 2 Diabetes with Conventional Insulin Regimen Failure , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[627]  Johan Groeneveld,et al.  A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study , 2009, Intensive Care Medicine.

[628]  Nilay Kumar,et al.  Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. , 2007, Diabetes technology & therapeutics.

[629]  Rury R Holman,et al.  Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). , 2003, Kidney international.

[630]  D. Nathan,et al.  A clinical trial to maintain glycemic control in youth with type 2 diabetes. , 2012, The New England journal of medicine.

[631]  M. S. Lewis,et al.  Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes , 2011, Annals of Internal Medicine.

[632]  D. DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.

[633]  J. Eng,et al.  Resistance and Agility Training Reduce Fall Risk in Women Aged 75 to 85 with Low Bone Mass: A 6‐Month Randomized, Controlled Trial * , 2004, Journal of the American Geriatrics Society.

[634]  Markolf Hanefeld,et al.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. , 2003, JAMA.

[635]  G. Landman,et al.  Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes , 2009, Diabetes Care.

[636]  S. Aronoff,et al.  Exenatide is Non-inferior to Insulin in Reducing HbA1c: An Integrated Analysis of 1423 Patients with Type 2 Diabetes , 2010, Postgraduate medicine.

[637]  G. Paolisso,et al.  Adiposity Predicts Cognitive Decline in Older Persons with Diabetes: A 2-Year Follow-Up , 2010, PloS one.

[638]  康生 大久保,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study , 1995 .

[639]  A. Vinik,et al.  Adding Insulin Glargine Versus Rosiglitazone , 2007, Diabetes Care.

[640]  D. Bruttomesso,et al.  Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy , 2009, Diabetes/metabolism research and reviews.

[641]  C. Janson,et al.  CPAP treatment of a population-based sample--what are the benefits and the treatment compliance? , 2006, Sleep medicine.

[642]  E. Ford,et al.  Prevalence of Diabetes and High Risk for Diabetes Using A1C Criteria in the U.S. Population in 1988–2006 , 2010, Diabetes Care.

[643]  H. Nawaz,et al.  Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. , 2003, Diabetes care.

[644]  B. Klein,et al.  Global Prevalence and Major Risk Factors of Diabetic Retinopathy , 2012, Diabetes Care.